Nido Biosciences logo

Nido Biosciences Funding & Investors

Nido Biosciences is a clinical-stage company that develops precision medicines for severe neurological diseases. Nido Bio is developing solutions for severe neurological illnesses based on today's advances in neuroscience. The company creates precise medications using human genetics that treat the underlying biology of disease and restore healthy cell function.

nidobio.com

Total Amount Raised: $109,000,000

Nido Biosciences Funding Rounds

  • Series B

    $86,600,000

    Series B Investors

    Bioluminescence Ventures
  • Series A

    $18,400,000

    Series A Investors

    5am Ventures
    Abingworth
    Bessemer Venture Partners
    OUP Management
    Eli Lilly
    Dreavent
  • Seed

    $4,000,000

    Seed Investors

    5am Ventures
Funding info provided by Diffbot.